oncology
-
Top 10 best-selling oncology drugs
The bright past is worth learning from by R&D personnel of later generations and their role and responsibility is to realize the commercialization of today’s cutting-edge technologies
-
With global innovation map further expanded, Ascentage Pharma saw a 477% surge in revenue in the first half of 2024
The development of original new drugs has always been considered a high-risk industry. A d…
-
Morphic’s stock prices soar by 75%! Eli Lilly invests an additional $3.2 billion in the autoimmune field
DrugTimes will present more reports timely. Please stay tuned
-
Gilead | A Ray of Hope for the Highly Anticipated TROP2 ADC Trodelvy
DrugTimes team will follow up on this hot field and report timely. Please stay tuned. Many thanks!~